Evidence map›Paper›PMID 39207152›Full record

ArticleAntimicrobial agents and chemotherapy2024

The fungal natural product fusidic acid demonstrates potent activity against

Gwendolyn E Wood, Jin Woo Lee, Thilini Peramuna, Karen L Wendt, Caroline M Kim, Laarni Kendra T Aguila, Claire L Calderon, Robert H Cichewicz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Mechanisms of fusidic acid resistance.Biochemical Society transactions · 2025
    Review
  3. AutomatedMicrobiology spectrum · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gwendolyn E WoodDepartment of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-5109-3794
Jin Woo LeeCollege of Pharmacy, Duksung Women's University, Seoul, Republic of Korea.
Thilini PeramunaNatural Products Discovery Group, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center, Institute for Natural Products Applications and Research Technologies, University of Oklahoma, Norman, Oklahoma, USA.
Karen L WendtNatural Products Discovery Group, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center, Institute for Natural Products Applications and Research Technologies, University of Oklahoma, Norman, Oklahoma, USA.
Caroline M KimDepartment of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.
Laarni Kendra T AguilaDepartment of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-8695-6684
Claire L CalderonDepartment of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.
Robert H CichewiczNatural Products Discovery Group, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center, Institute for Natural Products Applications and Research Technologies, University of Oklahoma, Norman, Oklahoma, USA.

Funding

Fungal natural products targeting antimicrobial resistant Mycoplasma genitaliumR21AI153863 · NIAID · UNIVERSITY OF OKLAHOMA · PI CICHEWICZ, ROBERT HENRY, WOOD, GWENDOLYN · 2021 to 2022
$441k
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R21AI153863NIAID NIH HHS R21 AI153863
6 · The paper itself

Abstract

Antimicrobial resistance is extremely common in

Indexed as

Anti-Bacterial AgentsFusidic AcidMicrobial Sensitivity TestsMycoplasma genitaliumAscomycotaBiological ProductsDrug Resistance, BacterialFemaleHumansMycoplasma InfectionsAnti-Bacterial AgentsBiological ProductsFusidic Acidantimicrobial resistancefungal natural productsfusidic acidMycoplasma genitalium

Identifiers

PMID39207152
PMCPMC11459954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.